Oncology Nurses' Educational Needs Regarding Genomic and Genetic Tests in the Era of Precision Oncology

ABSTRACT Objectives We sought to assess oncology nurses’ general knowledge of cancer genomics and genetics, evaluate oncology nurses’ application of genomics and biomarkers in oncology nursing practice, and determine oncology nurses’ educational needs and learning preferences related to cancer genomics and biomarkers. Methods All the oncology nurses who care for cancer patients in an academic medical center (n=900) were sent an email to complete the Oncology Nursing Survey of Genomics and Biomarkers in the Era of Precision Cancer Care. The survey obtained information on general knowledge of cancer genomics/genetics and biomarkers, application of genomics and biomarkers in oncology clinical practice, and learning needs of oncology nurses. Descriptive statistics were calculated for responses to the survey items. Results The survey response rate was 22.4%. The majority of the oncology nurses rated their understanding of the genetics of common diseases as poor. The majority of the nurses knew the difference between somatic and germline mutations, as well as various genetic variations. While only 9.4% of the nurses indicated that they had received formal education about genomics, greater than 50% had taken continuing education courses or “were learning on the job.” More than 80% of nurses wanted more education on how genomics and biomarkers influence cancer care. Conclusion Our findings highlight the need for increased education about the purpose and clinical utility of biomarker testing. Oncology nurses are integral to the testing process due to their involvement in coordination of care, triaging of results, and ongoing patient advocacy efforts. Implications for Practice The findings can be used to guide the development and implementation of educational programs. However, optimal approaches to integrating genomics into oncology nursing practice will require international educational guidelines that outline effective implementation strategies. Research is needed to determine the most effective approaches to translate genomic evidence into clinical practice and improve patient care.